LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| WADA classification | S4 Hormone and Metabolic Modulators | Prohibited at all times in sport. |
| Drug approval status | Not approved in major jurisdictions | No accepted therapeutic indication. |
| Common detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Typical test matrix | Urine or blood | Urine is common in anti-doping testing. |
| Product labeling | Research chemical or supplement | Often not independently verified. |
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
where J is the permeate flux which is the volumetric flow rate per unit of membrane area. The solute sieving coefficient and hydraulic permeability allow the quick assessment of the synthetic membrane performance.
She trained at the London Academy of Music and Dramatic Art and her stage work has included appearances with the National Theatre and the Royal Shakespeare Company. She was made a dame in the 2020 Queen's Birthday Honours for services to charity, entertainment and the arts. David Littman (activist) (4 July 1933 – 20 May 2012) author of over five books and scores of monographs and academic papers and activist best known for organising the departure of Jewish children from Morocco; then worked as lobbyist at the United Nations in Geneva and was also historian. He was married to Bat Ye'or. Emanuel Litvinoff, novelist. (5 May 1915 – 24 September 2011) was a British writer and well-known figure in Anglo-Jewish literature, known for novels, short stories, poetry, plays and human rights campaigning. Litvinoff became aware of plight of persecuted Soviet Jews, and started worldwide campaign against this persecution. Due to Litvinoff's efforts, prominent Jewish groups in United States became aware of issue, and well-being of Soviet Jews became cause for a worldwide campaign, eventually leading to mass migration of Jews from the Soviet Union to Israel and the United States. For this he has been described by Meir Rosenne, former Israeli ambassador to the United States, as "one of the greatest unsung heroes of the twentieth century... who won in the fight against an evil empire" and that "thousands and thousands of Russian Jews owe him their freedom".
The blood clot is only a temporary solution to stop bleeding; tissue repair is needed. Small interruptions in the endothelium are handled by physiological mechanisms; large interruptions by a trauma surgeon. The fibrin is slowly dissolved by the fibrinolytic enzyme, plasmin, and the platelets are cleared by phagocytosis. Platelets release platelet-derived growth factor (PDGF), a potent chemotactic agent; and TGF beta, which stimulates the deposition of extracellular matrix; fibroblast growth factor, insulin-like growth factor 1, platelet-derived epidermal growth factor, and vascular endothelial growth factor. Local application of these factors in increased concentrations through platelet-rich plasma (PRP) is used as an adjunct in wound healing.
As relations between Washington and Moscow improved, both governments increasingly worked to restrain their respective regional allies—pressuring their former proxies to make peace with one another—and establish negotiated settlements instead, while the US concomitantly stressed market globalization. In southern Africa, Soviet and Cuban support for the Angolan government diminished as diplomacy advanced, while the United States reduced backing for anti-communist insurgents, enabling peace processes that culminated in the late 1980s. Overall, this détente which accompanied the final twilight of the Cold War would help bring about a relatively more peaceful international environment. As a consequence of the Revolutions of 1989 and the adoption of a foreign policy based on non-interference by the Soviet Union, the Warsaw Pact rapidly lost its political and military rationale and began to dissolve. Meanwhile, troops stationed across eastern Europe began returning to the Soviet Union, completing their withdrawal by the mid-1990s. This marked the end of the Soviet military presence that had defined the political order in Europe since 1945. For all the complexity and geopolitical strain that the great power competition of the Cold War brought onto Europe during the second half of the 20th century, its trajectory turned out to be both "more prosperous and peaceful for Europeans than the first," so quips German historian Konrad Jarausch.
Within hours of his January 2025 inauguration, Trump signed an executive order withdrawing the country from the 2015 Paris Agreement, joining only Iran, Libya and Yemen as the only countries not party to the agreement. The same day, Trump issued Executive Order 14154, "Unleashing American Energy", which included pausing funding for the Inflation Reduction Act, introducing uncertainty as to the energy transition. His administration soon renewed a practice from his first term: removing mentions of climate change across numerous federal government websites that had been reinstated during Joe Biden's intervening term. In February 2025, the administration terminated the Environmental and Climate Justice Block Grant Program. In June 2026, district judge Richard Gergel ruled that the terminations were unlawful and in July 2026 a federal judge ordered the program's remaining $2.8 billion in funds be distributed. In April, Trump dismissed the scientists and experts who compile the National Climate Assessments (NCAs) that are required by Congress, the next assessment having been planned for 2028. The globalchange.gov website—established in 1990 to host legislatively mandated reports such as the NCAs—was taken down altogether at the end of June. In May 2025, NOAA said that its National Centers for Environmental Information would no longer update its Billion-Dollar Weather and Climate Disasters database beyond 2024, and that its information—going as far back as 1980—would be archived.
Sources: en.wikipedia.org
Calendula arvensis (Vaill.) L. – field marigold, wild marigold Calendula denticulata Schousb. ex Willd. Calendula eckerleinii Ohle Calendula incana Willd. Calendula incana subsp. algarbiensis (Boiss.) Ohle Calendula incana subsp. maderensis (DC.) Ohle – Madeiran marigold Calendula incana subsp. maritima (Guss.) Ohle – sea marigold Calendula incana subsp. microphylla (Lange) Ohle Calendula lanzae Maire Calendula maritima Guss. - sea marigold Calendula maroccana (Ball) Ball Calendula maroccana subsp. maroccana Calendula maroccana subsp. murbeckii (Lanza) Ohle Calendula meuselii Ohle Calendula officinalis L. – pot marigold, garden marigold, ruddles, Scottish marigold Calendula palaestina Boiss. Calendula stellata Cav. Calendula suffruticosa Vahl Calendula suffruticosa subsp. balansae (Boiss. & Reut.) Ohle Calendula suffruticosa subsp. boissieri Lanza Calendula suffruticosa subsp. fulgida (Raf.) Guadagno Calendula suffruticosa subsp. lusitanica (Boiss.) Ohle Calendula suffruticosa subsp. maritima (Guss.) Meikle Calendula suffruticosa subsp. monardii (Boiss. & Reut.) Ohle Calendula suffruticosa subsp. tomentosa Murb. Calendula tripterocarpa Rupr.
== Airlines and destinations == In 2025, Hohhot Baita International Airport plans to operate 139 routes, serving 92 cities in total, including 83 nonstop destinations and 6 international or regional cities.
== Shelf-life and safety == The purpose of IMF foods is to achieve a water activity that the food can be stored safely without refrigeration. However, the food is not sterile. Staphylococcus aureus is a microorganism of concern as it can grow and produce specific enterotoxins in water activities of 0.83-0.86 under aerobic conditions. Because of this, proper handling, storage, hygiene and good manufacturing practices are necessary to prevent Staphylococcus aureus. Molds of Aspergillis and Penicillium species can grow and produce harmful mycotoxins at water activity 0.77-0.85. Salmonella and Bacillus cereus are the primary pathogens of concern with low-moisture foods and IMFs. Most illnesses associated with low-moisture foods or IMFs have been caused by Salmonella spp. To reduce the risk of bacterial growth, products are treated with a combination of low pH, addition of sugar, salt and preservatives, and a thermal process that can eliminate pathogens and extend shelf-life. In the case of yeasts and molds, chemical preservatives such as sorbates and propionates are used to inhibit their growth.
In the United States, the term "nickel" or "nick" originally applied to the copper-nickel Flying Eagle cent, which replaced copper with 12% nickel 1857–58, then the Indian Head cent of the same alloy from 1859 to 1864. Still later, in 1865, the term designated the three-cent nickel, with nickel increased to 25%. In 1866, the five-cent shield nickel (25% nickel, 75% copper) appropriated the designation, which has been used ever since for the subsequent 5-cent pieces. This alloy proportion is not ferromagnetic. The US nickel coin contains 0.04 ounces (1.1 g) of nickel, which at the April 2007 price was worth 6.5 cents, along with 3.75 grams of copper worth about 3 cents, with a total metal value of more than 9 cents. Since the face value of a nickel is 5 cents, this made it an attractive target for melting by people wanting to sell the metals at a profit. The United States Mint, anticipating this practice, implemented new interim rules on December 14, 2006, subject to public comment for 30 days, which criminalized the melting and export of cents and nickels. Violators can be punished with a fine of up to $10,000 and/or a maximum of five years in prison. As of February 19, 2025, the melt value of a US nickel (copper and nickel included) is $0.054 (108% of the face value).
When NBOMes are administered sublingually, numbness of the tongue and mouth followed by a metallic chemical taste was observed, and researchers describe this physical side effect as one of the main discriminants between NBOMe compounds and LSD.
Sources: en.wikipedia.org
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.
Legality varies by country and context. It lacks marketing approval as a medicine in major countries. Sports organizations prohibit its use at all times.
A certificate of analysis may report identity, purity, and testing methods for a specific batch. It does not guarantee safety or legal status. Independent verification can confirm whether the material matches the label.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.